ArticleEBioMedicine2016

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma.

Nicolai J Wewer Albrechtsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.